Joseph P. Lucia & Associates, LLC Moderna, Inc. Transaction History

Joseph P. Lucia & Associates, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$117.13 - $176.59 $41,581 - $62,689	-355 Reduced 37.25%	598 $85,000
Q1 2022 Apr 19, 2022	BUY	$126.46 - $235.05 $3,161 - $5,876	25 Added 2.69%	953 $164,000
Q4 2021 Feb 04, 2022	SELL	$225.82 - $368.51 $5,645 - $9,212	-25 Reduced 2.62%	928 $236,000
Q3 2021 Oct 13, 2021	SELL	$221.9 - $484.47 $17,752 - $38,757	-80 Reduced 7.74%	953 $367,000
Q2 2021 Jul 27, 2021	BUY	$129.91 - $234.98 $10,522 - $19,033	81 Added 8.51%	1,033 $243,000
Q1 2021 Apr 23, 2021	SELL	$109.18 - $185.98 $58,738 - $100,057	-538 Reduced 36.11%	952 $125,000
Q4 2020 Jan 29, 2021	BUY	$65.74 - $169.86 $97,952 - $253,091	1,490 New	1,490 $156,000
Q3 2020 Oct 20, 2020	SELL	$54.34 - $94.85 $80,966 - $141,326	-1,490 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$29.67 - $80.0 $44,208 - $119,200	1,490 New	1,490 $96,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.